Allogene Therapeutics
ALLO
$2.97
Share price
1.71%
Change (1 day)
-44.49%
Change (1 year)
Categories
Allogene Therapeutics (ALLO) - Total debt
Total debt on the balance sheet as of December 2023 : $95.12 M
According to Allogene Therapeutics 's latest financial reports the company's total debt is $95.12 M. A company’s total debt is the sum of all current and non-current debts.
Allogene Therapeutics - Total debt on balance sheet (from 2018 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $0.10 B | 38.28% |
| 2021-12-31 | $73.12 M | 43.93% |
| 2020-12-31 | $50.8 M | -4.18% |
| 2019-12-31 | $53.02 M | 53.9% |
| 2018-12-31 | $34.45 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $2.75 M | -97.11% | 🇺🇸 USA |